Broadfoot Jill Marie
SEC CIK 1305178 · EDGAR
BoughtSold
Most active insiders at TLPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Angotti Vincent J. | CEO, Dir | $211.2K | — |
| 2 | ASADORIAN RAFFI | CFO | $36.5K | — |
| 3 | Aslam Shakil | Chief Medical Off | $28.4K | — |
| 4 | Dasu Badri N | Chief Engineering Off | $28.4K | — |
| 5 | JAIN ABHINAV | Dir | — | — |
| 6 | Bozilenko Marina | Dir | — | — |
| 7 | Todisco Joseph | Dir | — | — |
| 8 | Broadfoot Jill Marie | Dir | — | — |
| 9 | ADAMS ADRIAN | Dir | — | — |
| 10 | WAN MARK A | Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-24 17:10 | 2026-06-22 | TLPH | TALPHERA, INC. | Broadfoot Jill Marie | Dir | A - Grant | $0.00 | +5,100 | 13.6K | +60% | $0 |
| D | 2026-02-04 | 2026-02-03 | ATYR | aTYR PHARMA INC | Broadfoot Jill Marie | CFO | M - OptEx | — | +3,750 | 38.9K | +11% | — |
| D | 2026-02-04 | 2026-02-04 | ATYR | aTYR PHARMA INC | Broadfoot Jill Marie | CFO | S - Sale+OE | $0.98 | -1,558 | 37.3K | -4% | -$1,527 |
| D | 2025-10-24 | 2025-10-23 | TLPH | TALPHERA, INC. | Broadfoot Jill Marie | Dir | A - Grant | $0.00 | +4,267 | 8,547 | +100% | $0 |
| D | 2025-02-04 | 2025-02-03 | ATYR | aTYR PHARMA INC | Broadfoot Jill Marie | CFO | M - OptEx | — | +3,750 | 33.0K | +13% | — |
| D | 2025-02-04 | 2025-02-04 | ATYR | aTYR PHARMA INC | Broadfoot Jill Marie | CFO | S - Sale+OE | $3.78 | -1,254 | 31.8K | -4% | -$4,740 |
| D | 2024-06-24 | 2024-06-24 | TLPH | TALPHERA, INC. | Broadfoot Jill Marie | Dir | A - Grant | $0.00 | +2,174 | 4,280 | +103% | $0 |
| 2024-06-03 | 2024-05-31 | ATYR | aTYR PHARMA INC | Broadfoot Jill Marie | CFO | P - Purchase | $1.79 | +5,000 | 28.0K | +22% | +$8,950 | |
| D | 2024-02-06 | 2024-02-05 | ATYR | aTYR PHARMA INC | Broadfoot Jill Marie | CFO | M - OptEx | — | +3,750 | 22.4K | +20% | — |
| D | 2024-02-06 | 2024-02-06 | ATYR | aTYR PHARMA INC | Broadfoot Jill Marie | CFO | S - Sale+OE | $1.69 | -1,590 | 20.8K | -7% | -$2,687 |
| D | 2023-12-13 | 2023-10-10 | TLPH | TALPHERA, INC. | Broadfoot Jill Marie | Dir | A - Grant | $0.00 | +581 | 2,106 | +38% | $0 |
| D | 2023-02-06 | 2023-02-03 | ATYR | aTYR PHARMA INC | Broadfoot Jill Marie | CFO | M - OptEx | — | +3,750 | 17.0K | +28% | — |
| D | 2023-02-06 | 2023-02-06 | ATYR | aTYR PHARMA INC | Broadfoot Jill Marie | CFO | S - Sale+OE | $2.36 | -1,566 | 15.5K | -9% | -$3,696 |
| D | 2022-07-15 | 2022-07-15 | TLPH | TALPHERA, INC. | Broadfoot Jill Marie | Dir | A - Grant | $0.00 | +15.5K | 30.5K | +103% | $0 |
| 2022-01-18 | 2022-01-13 | ATYR | aTYR PHARMA INC | Broadfoot Jill Marie | CFO | P - Purchase | $6.75 | +1,923 | 12.1K | +19% | +$13.0K | |
| D | 2021-11-23 | 2021-11-20 | TLPH | TALPHERA, INC. | Broadfoot Jill Marie | Dir | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations